-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Viatris, Raises Price Target to $25

Benzinga·11/16/2026 15:56:14
Listen to the news
Barclays analyst Glen Santangelo maintains Viatris (NASDAQ:VTRS) with a Overweight and raises the price target from $22 to $25.